SEDECAL SA recalled 181 units of its Mobile X-ray system on June 10, 2025. The recall warns users that the equipment is not water-resistant and requires strict cleaning protocols. Improper cleaning may lead to serious consequences for patients and healthcare providers.
Sedecal sent an email to its consignees to remind the users that the equipment is not water-resistant and must be cleaned strictly according to the instructions in the manual, clearly outlining the possible consequences of improper cleaning.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact SEDECAL SA or your healthcare provider for instructions. Notification method: E-Mail
The recalled product is the Mobile X-ray system, Model Number SM-40HF-B-D-C; 40KW 70C. It was distributed in California, Illinois, and New Jersey.
The Mobile X-ray system is not water-resistant, which poses a risk of electrical hazards if improperly cleaned. Users must adhere strictly to the cleaning instructions provided in the manual.
There have been no reported injuries or incidents associated with this recall. All users are advised to follow the manufacturer's cleaning instructions to prevent any potential hazards.
Stop using the Mobile X-ray system immediately. Contact SEDECAL SA or your healthcare provider for further instructions regarding the recall.
For further information, visit SEDECAL's website or contact them directly. The recall notification was sent via email to consignees.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.